Cosulich, Sabina

AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with In vitro and In vivo Antitumor Activity

Chresta, C. M., Davies, B. R., Hickson, I., Harding, T., Cosulich, S., Critchlow, S. E., Vincent, J. P., Ellston, R., Jones, D., Sini, P., et al. (2010) · Cancer Research

PI3K/AKT/mTOR signaling in cancerAutophagy in Disease and Therapy

Cited by 812

Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor

Rodrik-Outmezguine, V. S., Okaniwa, M., Yao, Z., Novotny, C. J., McWhirter, C., Banaji, A., Won, H., Wong, W., Berger, M., de Stanchina, E., et al. (2016) · Nature

PI3K/AKT/mTOR signaling in cancerAdvanced Breast Cancer Therapies

Cited by 479

PTEN Regulates PI(3,4)P2 Signaling Downstream of Class I PI3K

Malek, M., Kielkowska, A., Chessa, T., Anderson, K. E., Barneda, D., Pir, P., Nakanishi, H., Eguchi, S., Koizumi, A., Sasaki, J., et al. (2017) · Molecular Cell

PI3K/AKT/mTOR signaling in cancerProtein Kinase Regulation and GTPase Signaling

Cited by 190

How is the acyl chain composition of phosphoinositides created and does it matter?

Barneda, D., Cosulich, S., Stephens, L., & Hawkins, P. (2019) · Biochemical Society Transactions

Lipid metabolism and biosynthesisProtein Kinase Regulation and GTPase Signaling

Cited by 65